REPORTS

Let’s Pullulate and Expand Your Business

Global Metabotropic Glutamate Receptor 5 Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 09, 2020  |  236 PAGES  |  REPORT CODE: CMM328922
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Metabotropic Glutamate Receptor 5 is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period. The research provides insights for the global Metabotropic Glutamate Receptor 5 market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Metabotropic Glutamate Receptor 5 industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Metabotropic Glutamate Receptor 5 Market Segmentations:

By Players:

  • Addex Therapeutics Ltd

  • Aevi Genomic Medicine Inc

  • Bristol-Myers Squibb Company

  • Eisai Co Ltd

  • Eli Lilly and Company

  • Heptares Therapeutics Ltd

  • Johnson & Johnson

  • Merz Pharma GmbH & Co KgaA

  • Novartis AG

  • Richter Gedeon Nyrt

  • Sumitomo Dainippon Pharma Co Ltd

  • Toray Industries Inc

By Types:

  • Alloswitch-1

  • BMS-952048

  • BMS-955829

  • Dipraglurant ER

  • Others

By End-User:

  • Major Depressive Disorder

  • Alcohol Assiction

  • Alzheimer's Disease

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Metabotropic Glutamate Receptor 5 Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1 from 2014 to 2026

    • 1.3.2 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048 from 2014 to 2026

    • 1.3.3 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829 from 2014 to 2026

    • 1.3.4 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER from 2014 to 2026

    • 1.3.5 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2014 to 2026

    • 1.4.2 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Assiction from 2014 to 2026

    • 1.4.3 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • 1.4.4 Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Metabotropic Glutamate Receptor 5 Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Metabotropic Glutamate Receptor 5 Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Metabotropic Glutamate Receptor 5 by Major Types

    • 3.4.1 Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1

    • 3.4.2 Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048

    • 3.4.3 Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829

    • 3.4.4 Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER

    • 3.4.5 Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others

4 Segmentation of Metabotropic Glutamate Receptor 5 Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Metabotropic Glutamate Receptor 5 by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Major Depressive Disorder

    • 4.4.2 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Alcohol Assiction

    • 4.4.3 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Alzheimer's Disease

    • 4.4.4 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Others

5 Market Analysis by Major Regions

  • 5.1 Global Metabotropic Glutamate Receptor 5 Production Analysis by Major Regions

  • 5.2 Global Metabotropic Glutamate Receptor 5 Consumption Analysis by Major Regions

  • 5.3 Global Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

6 Product Commodity of Metabotropic Glutamate Receptor 5 Market in Major Countries

  • 6.1 Top 5 Export Countries in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Metabotropic Glutamate Receptor 5 Landscape Analysis

  • 7.1 North America Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

  • 7.2 North America Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

  • 7.3 North America Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Countries

    • 7.3.1 United States Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 7.3.2 Canada Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 7.3.3 Mexico Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

8 Europe Metabotropic Glutamate Receptor 5 Landscape Analysis

  • 8.1 Europe Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

  • 8.2 Europe Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

  • 8.3 Europe Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Countries

    • 8.3.1 Germany Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.2 UK Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.3 France Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.4 Italy Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.6 Spain Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.7 Belgium Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.8 Poland Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.9 Russia Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 8.3.10 Turkey Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

9 Asia Pacific Metabotropic Glutamate Receptor 5 Landscape Analysis

  • 9.1 Asia Pacific Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

  • 9.2 Asia Pacific Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Countries

    • 9.3.1 China Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 9.3.2 Japan Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 9.3.4 India Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 9.3.6 South Korea Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

10 Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 10.3.2 Brazil Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 10.3.3 Nigeria Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

    • 10.3.4 South Africa Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate 

    • 10.3.5 Argentina Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Addex Therapeutics Ltd

    • 11.1.1 Addex Therapeutics Ltd Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Aevi Genomic Medicine Inc

    • 11.2.1 Aevi Genomic Medicine Inc Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Bristol-Myers Squibb Company

    • 11.3.1 Bristol-Myers Squibb Company Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Eisai Co Ltd

    • 11.4.1 Eisai Co Ltd Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Eli Lilly and Company

    • 11.5.1 Eli Lilly and Company Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Heptares Therapeutics Ltd

    • 11.6.1 Heptares Therapeutics Ltd Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Johnson & Johnson

    • 11.7.1 Johnson & Johnson Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Merz Pharma GmbH & Co KgaA

    • 11.8.1 Merz Pharma GmbH & Co KgaA Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Novartis AG

    • 11.9.1 Novartis AG Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Richter Gedeon Nyrt

    • 11.10.1 Richter Gedeon Nyrt Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Sumitomo Dainippon Pharma Co Ltd

    • 11.11.1 Sumitomo Dainippon Pharma Co Ltd Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Toray Industries Inc

    • 11.12.1 Toray Industries Inc Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 95 Figures and 174 Tables)

  • Figure Product Picture

  • Figure Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1 from 2014 to 2026

  • Figure Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048 from 2014 to 2026

  • Figure Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829 from 2014 to 2026

  • Figure Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER from 2014 to 2026

  • Figure Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2014 to 2026

  • Figure Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Assiction from 2014 to 2026

  • Figure Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

  • Figure Global Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Metabotropic Glutamate Receptor 5 Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Metabotropic Glutamate Receptor 5

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Metabotropic Glutamate Receptor 5 by Different Types from 2014 to 2026

  • Table Consumption Share of Metabotropic Glutamate Receptor 5 by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Alloswitch-1

  • Figure Market Size and Growth Rate of BMS-952048

  • Figure Market Size and Growth Rate of BMS-955829

  • Figure Market Size and Growth Rate of Dipraglurant ER

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Metabotropic Glutamate Receptor 5 by Different End-Users from 2014 to 2026

  • Table Consumption Share of Metabotropic Glutamate Receptor 5 by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Major Depressive Disorder

  • Figure Market Size and Growth Rate of Alcohol Assiction

  • Figure Market Size and Growth Rate of Alzheimer's Disease

  • Figure Market Size and Growth Rate of Others

  • Table Global Metabotropic Glutamate Receptor 5 Production by Major Regions

  • Table Global Metabotropic Glutamate Receptor 5 Production Share by Major Regions

  • Figure Global Metabotropic Glutamate Receptor 5 Production Share by Major Regions in 2014

  • Figure Global Metabotropic Glutamate Receptor 5 Production Share by Major Regions in 2018

  • Figure Global Metabotropic Glutamate Receptor 5 Production Share by Major Regions in 2026

  • Table Global Metabotropic Glutamate Receptor 5 Consumption by Major Regions

  • Table Global Metabotropic Glutamate Receptor 5 Consumption Share by Major Regions

  • Figure Global Metabotropic Glutamate Receptor 5 Consumption Share by Major Regions in 2014

  • Figure Global Metabotropic Glutamate Receptor 5 Consumption Share by Major Regions in 2018

  • Figure Global Metabotropic Glutamate Receptor 5 Consumption Share by Major Regions in 2026

  • Table North America Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

  • Table Europe Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Metabotropic Glutamate Receptor 5 market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

  • Table North America Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

  • Table North America Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

  • Table North America Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

  • Table North America Metabotropic Glutamate Receptor 5 Consumption by Major Countries from 2014 to 2026

  • Table North America Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2014

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2018

  • Figure North America Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2026

  • Figure United States Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

  • Table Europe Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

  • Table Europe Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

  • Table Europe Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

  • Table Europe Metabotropic Glutamate Receptor 5 Consumption by Major Countries from 2014 to 2026

  • Table Europe Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2014

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2018

  • Figure Europe Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2026

  • Figure Germany Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure France Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2026

  • Figure China Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandMetabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure India Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Metabotropic Glutamate Receptor 5 Consumption Share by Major Countries in 2026

  • Figure GCC Countries Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Metabotropic Glutamate Receptor 5 Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Addex Therapeutics Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Therapeutics Ltd

  • Figure Sales and Growth Rate Analysis of Addex Therapeutics Ltd

  • Figure Revenue and Market Share Analysis of Addex Therapeutics Ltd

  • Table Product and Service Introduction of Addex Therapeutics Ltd

  • Table Company Profile and Development Status of Aevi Genomic Medicine Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aevi Genomic Medicine Inc

  • Figure Sales and Growth Rate Analysis of Aevi Genomic Medicine Inc

  • Figure Revenue and Market Share Analysis of Aevi Genomic Medicine Inc

  • Table Product and Service Introduction of Aevi Genomic Medicine Inc

  • Table Company Profile and Development Status of Bristol-Myers Squibb Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

  • Table Product and Service Introduction of Bristol-Myers Squibb Company

  • Table Company Profile and Development Status of Eisai Co Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co Ltd

  • Figure Sales and Growth Rate Analysis of Eisai Co Ltd

  • Figure Revenue and Market Share Analysis of Eisai Co Ltd

  • Table Product and Service Introduction of Eisai Co Ltd

  • Table Company Profile and Development Status of Eli Lilly and Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

  • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

  • Figure Revenue and Market Share Analysis of Eli Lilly and Company

  • Table Product and Service Introduction of Eli Lilly and Company

  • Table Company Profile and Development Status of Heptares Therapeutics Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heptares Therapeutics Ltd

  • Figure Sales and Growth Rate Analysis of Heptares Therapeutics Ltd

  • Figure Revenue and Market Share Analysis of Heptares Therapeutics Ltd

  • Table Product and Service Introduction of Heptares Therapeutics Ltd

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of Merz Pharma GmbH & Co KgaA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma GmbH & Co KgaA

  • Figure Sales and Growth Rate Analysis of Merz Pharma GmbH & Co KgaA

  • Figure Revenue and Market Share Analysis of Merz Pharma GmbH & Co KgaA

  • Table Product and Service Introduction of Merz Pharma GmbH & Co KgaA

  • Table Company Profile and Development Status of Novartis AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

  • Figure Sales and Growth Rate Analysis of Novartis AG

  • Figure Revenue and Market Share Analysis of Novartis AG

  • Table Product and Service Introduction of Novartis AG

  • Table Company Profile and Development Status of Richter Gedeon Nyrt

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Richter Gedeon Nyrt

  • Figure Sales and Growth Rate Analysis of Richter Gedeon Nyrt

  • Figure Revenue and Market Share Analysis of Richter Gedeon Nyrt

  • Table Product and Service Introduction of Richter Gedeon Nyrt

  • Table Company Profile and Development Status of Sumitomo Dainippon Pharma Co Ltd

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma Co Ltd

  • Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma Co Ltd

  • Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma Co Ltd

  • Table Product and Service Introduction of Sumitomo Dainippon Pharma Co Ltd

  • Table Company Profile and Development Status of Toray Industries Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Toray Industries Inc

  • Figure Sales and Growth Rate Analysis of Toray Industries Inc

  • Figure Revenue and Market Share Analysis of Toray Industries Inc

  • Table Product and Service Introduction of Toray Industries Inc


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top